Quick Answer
Xtant Medical Holdings, Inc. reported Revenue (ASC 606) of $133.93 million for fiscal year 2025.
Xtant Medical Holdings, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $133.93M | +14.2% |
| 2024 | $117.27M | +28.4% |
| 2023 | $91.30M | +57.5% |
| 2022 | $57.97M | +4.9% |
| 2021 | $55.26M | +3.6% |
| 2020 | $53.34M | -17.5% |
| 2019 | $64.68M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $33.26M | +19.0% | -6.1% |
| June 30, 2025 | $35.41M | +18.3% | +7.6% |
| March 31, 2025 | $32.90M | +18.0% | +17.8% |
| September 30, 2024 | $27.94M | +11.7% | -6.7% |
| June 30, 2024 | $29.94M | +48.0% | +7.4% |
| March 31, 2024 | $27.87M | +55.3% | +11.4% |
| September 30, 2023 | $25.02M | +73.0% | +23.7% |
| June 30, 2023 | $20.23M | +32.4% | +12.8% |
- Xtant Medical Holdings, Inc. showed an increase of +14.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2019–2025 period, Xtant Medical Holdings, Inc.’s revenue (asc 606) has grown by 107.1% (from $64.68 million to $133.93 million).
- The most recent figure is from Xtant Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: